Therapeutic Areas

Psychedelic Assisted Therapies

As part of our clinical research capabilities, we investigate psychedelic-assisted therapies to explore new treatment options for mental health and addiction.

Our guided therapeutic model includes preparation, a supervised dosing session, and a follow-up session. We use the following substances in our research:

• 3,4-methylenedioxymethamphetamine (MDMA)

• Ayahuasca

• Dimethyltryptamine (DMT)

• Ibogaine

• Lysergic acid diethylamide (LSD)

• Psilocybin (mushrooms)

​

​We target multiple conditions with psychedelic-assisted therapy, including PTSD, treatment-resistant depression, end-of-life anxiety, and addiction.

Therapeutic Areas

Internal Medicine